Evidence map›Paper›PMID 42370155›Full record

ArticleFrontiers in oncology2026

Case Report: Ultrasound-guided percutaneous splenic biopsy as a lifesaving diagnostic modality in B-cell lymphoma presenting as hemophagocytic lymphohistiocytosis: a report of two cases.

Zhuohang Zou, Yang Dai, Xushu Zhong, Jun Wang, Ailin Zhao, Yijun Wu, Ting Niu

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhuohang Zou *Department of Hematology, Institute of Hematology, and Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yang Dai *Department of Hematology, Institute of Hematology, and Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xushu ZhongDepartment of Hematology, Institute of Hematology, and Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Jun WangDepartment of Medical Ultrasound, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Ailin ZhaoDepartment of Hematology, Institute of Hematology, and Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yijun WuDepartment of Hematology, Institute of Hematology, and Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Ting NiuDepartment of Hematology, Institute of Hematology, and Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hemophagocytic lymphohistiocytosis (HLH) as the initial manifestation of B-cell lymphoma poses significant diagnostic challenges, particularly when conventional tissue biopsy is contraindicated due to severe cytopenias and coagulopathy. Case description: We report two cases of B-cell lymphoma initially presenting with HLH, fulfilling HLH-2004 diagnostic criteria. Given the predominant splenic involvement and high bleeding risk, ultrasound-guided percutaneous splenic biopsy was performed, yielding a definitive histopathological diagnosis and guiding subsequent targeted therapy. Conclusion: Ultrasound-guided percutaneous splenic biopsy may serve as a viable diagnostic option in carefully selected patients with lymphoma-associated HLH and predominant splenic involvement, particularly when conventional approaches are inadequate or contraindicated. Its application requires thorough multidisciplinary risk-benefit assessment.

Indexed as

diagnostic dilemmahemophagocytic lymphohistiocytosislymphomasplenic lymphomaultrasound-guided percutaneous splenic biopsy

Identifiers

PMID42370155
PMCPMC13303101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.